The Green Organic Dutchman Announces Stock Option and RSU Grants – Yahoo Finance

TORONTO, Dec. 2, 2021 /PRNewswire/ – The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (CSE: TGOD) (USOTC: TGODF), a sustainable global cannabis company, announces that it has granted options (each, an "Option") to purchase an aggregate of up to 2,516,000 common shares of the Company (the "Common Shares") to certain directors, officers, employees, and consultants of the Company, of which 1,500,000 Options were granted to recently appointed directors and officers, and 1,016,000 Options were granted to employees and consultants. Each Option is exercisable into one Common Share at an exercise price per Common Share equal to $0.14. The Options vest as to 1/3 of the total number of Options granted on each of the first, second and third anniversaries of the grant date, and expire five years from the grant date. The Options are granted in accordance with the Company's share option plan adopted by the board of directors of the Company on May 12, 2021 (the "Option Plan").
Pursuant to the terms of the Company's amended and restated restricted share unit plan dated October 9, 2020 (the "RSU Plan"), 100,000 restricted share units ("RSUs") were also awarded to recently appointed directors and an officer of the Company, which will vest in two equal tranches, on each of the first and second anniversaries of the grant date. Copies of the Option Plan and the RSU Plan are available under the Company's SEDAR profile at
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) (US–OTC: TGODF) is a sustainable, global cannabis company with a focus on innovation, quality, consistency, integrity and transparency. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. In Canada, TGOD serves the recreational market with a brand portfolio including The Green Organic Dutchman, Highly Dutch Organics, Ripple by TGOD and Cruuzy brands, and the medical markets in Canada, South Africa, Australia, and Germany. All cannabis utilized in products for The Green Organic Dutchman and Highly Dutch Organics brands is grown through a certified organic process, which includes living soil, filtered rainwater, sunlight, and natural inputs. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals in Europe.
TGOD's Common Shares and Warrants issued under the indentures dated December 19, 2019, June 12, 2020, October 23, 2020 and December 10, 2020 trade on the CSE under the symbol "TGOD", "TGOD.WS", "TGOD.WR", "TGOD.WA", and "TGOD.WB" respectively. TGOD's Common Shares trade in the U.S. on the OTCQX under the symbol "TGODF". For more information on The Green Organic Dutchman Holdings Ltd., please visit
Cautionary Statements
This news release includes statements containing certain "forward–looking information" within the meaning of applicable securities law ("forward–looking statements"). Forward–looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "should", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward–looking statements throughout this news release. Forward–looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward–looking statements, including those risk factors described in the Company's most recent Annual Information Form filed with Canadian securities regulators and available on the Company's issuer profile on SEDAR at Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward–looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither the CSE nor the CSE's Regulation Services Provider (as that term is defined in the policies of CSE) accept responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE The Green Organic Dutchman Holdings Ltd.
Share prices of Lucid Group (NASDAQ: LCID) and Nio (NYSE: NIO) are down over 10% since Monday. Let's dive into Lucid and Nio to see if each company has what it takes to endure today's short-term pain for a potential long-term gain.
AT&T (NYSE: T) was once considered a stable blue-chip stock for income investors. AT&T's decline can be traced back to three big mistakes. First, it bought DirecTV for $49 billion in 2015 in an ill-fated attempt to expand its pay-TV business.
DocuSign shares get whacked as a surprising slowdown in its business rattles investors. DocuSign weighs in on the outlook on Yahoo Finance Live.
Friday is looking like a lousy day to own unprofitable electric vehicle (EV) stocks. Up and down the supply chain — from the companies that mine lithium to those that turn lithium into battery packs to those building networks of charging stations — all EV stocks are tumbling.
The SEC just made it clear that it's serious about delisting Chinese stocks from U.S. exchanges if the companies don't follow its financial disclosure rules.
It has been a little over a year since Palantir Technologies' (NYSE: PLTR) much-celebrated initial public offering, which saw the stock jump nearly 150% from its initial trade through September. Palantir is a data analytics company that sells to both the government and the private sector. Its tech is well regarded, and credited both with helping the Pentagon find Osama bin Laden and with sniffing out the Bernie Madoff fraud.
In this article, we discuss the 10 stocks to watch in the portfolio of Warren Buffett. If you want to skip our detailed analysis of these stocks, go directly to Warren Buffett’s Picks: 5 Stocks to Watch. Warren Buffett is famous in the finance world for his legendary value investing strategies. The long-term stock picks […] Partner and Director of Trading Research & Education Michele Schneider joins Yahoo Finance Live to analyze small cap stocks and thematic ETFs.
The business plans of QuantumScape and EVgo have remained on track, but Arrival's schedule has been derailed.
Share prices of Walt Disney (NYSE: DIS) just crashed to a fresh 52-week low and are down nearly 35% from their all-time high. After pushing Disney's risks out in the open and weighing them against its pros, it's clear that Disney is undoubtedly my top stock to buy for 2022. Fears that the Omicron COVID-19 variant could impact attendance at movie theaters and Disney parks are a real threat.
Yahoo Finance's Jared Blikre provides the numbers to know from Marvell's Q3 earnings. 
Shares of DocuSign (NASDAQ: DOCU) were crushed in early trading Friday, plunging as much as 41.4%. While DocuSign's revenue and earnings beat estimates, several factors suggest rapidly decelerating revenue growth. For its fiscal 2022 third quarter (ended Oct. 31), DocuSign delivered revenue of $545.5 million, up 42% year over year, driven by subscription revenue of $528.6 million, up 44%.
In the U.S., we now have Meta Platforms, Inc.(NASDAQ: FB), but in Latin America, there's soon going to be Meka. Meka is a partnership between e-commerce giant MercadoLibre (NASDAQ: MELI) and venture capital firm Kaszek, which was founded to invest in leading Latin American technology companies. Between its incredible growth and new stakes in early-stage tech companies — is MercadoLibre on course to become one of the biggest technology companies in the world?
Shares of (NYSE: AI) tumbled out of the gate Thursday, plunging as much as 18.7%, though the stock recovered somewhat, ending the day down just 11.2%. For the fiscal second quarter (ended Oct. 31), delivered revenue of $58.3 million, up 41% year over year, driven by subscription revenue of $47.4 million, up 32%. The company's remaining performance obligation (RPO), which consists of contractually obligated sales that have yet to be recognized as revenue, surged to $465.5 million, up more than 74% year over year, suggesting that business will continue to thrive for the foreseeable future.
Shares of Dynavax Technologies (NASDAQ: DVAX) were tumbling 7.9% lower at 11:04 a.m. ET on Friday. The only news from the company was an announcement after market close on Thursday that it had granted stock options to five new employees that allow them to purchase a total of 58,500 shares. No. Companies routinely give stock options to attract and retain employees.
Yahoo Finance Live host Julie Hyman breaks down several of the leading national headlines.
Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965. Over that time, he's led Berkshire to an average annual gain of about 20%, which translates into aggregate gains, including the year-to-date performance of the Class A shares (BRK.A), of approximately 3,500,000%. Based on the latest 13F filing with the Securities and Exchange Commission, Berkshire Hathaway has stakes in 45 securities.
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here. The RiverPark Large Growth Fund (the “Fund”) returned -3.23% for the third quarter of 2021, while its benchmarks, the S&P 500 Total Return Index (“S&P”) advanced 0.58%, the Russell […]
When it comes to healthcare companies, sometimes it pays to steer clear of crowd favorites. Today, I'll be weighing in on two healthcare stocks that I plan to avoid for the foreseeable future. The generic drugmaker Teva Pharmaceuticals (NYSE: TEVA) is a risky stock that's easy to mistake for a stalwart.
Shares of Virgin Galactic Holdings (NYSE: SPCE) dropped 9.9% this week, according to data from S&P Global Market Intelligence. Virgin Galactic is an aerospace company building rockets to take humans to space, either for recreational or research purposes, with the hopes of revolutionizing how we travel across the globe. The company went public through a special purpose acquisition company (SPAC) back in 2019 and has since traded wildly, falling in and out of favor and becoming a popular meme stock along the way.